12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
Healthcare stocks experienced significant movement during Monday's intraday session, with Benitec Biopharma, MoonLake, INVO Bioscience, Femasys, ORIC Pharmaceuticals, and Belite Bio among the gainers, while Avalo Therapeutics, FibroGen, BioVie, Pieris Pharmaceuticals, Entrada Therapeutics, and Bio-Path Hldgs were among the losers.
June 26, 2023 | 5:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Belite Bio's stock increased by 17.11% to $13.09 during Monday's session.
Belite Bio's stock experienced a significant increase during Monday's session. This indicates strong investor interest and could lead to further price increases in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Benitec Biopharma's stock increased by 99.8% to $0.4 during Monday's regular session, with a trading volume of 150.8 million.
Benitec Biopharma's stock experienced a significant increase during Monday's session, with a trading volume much higher than its average full-day volume over the last 100 days. This indicates strong investor interest and could lead to further price increases in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Femasys' shares rose 21.21% to $0.74 during Monday's session, with a trading volume of 28.0 million.
Femasys' shares experienced a significant increase during Monday's session, with a trading volume much higher than its average full-day volume over the last 100 days. This indicates strong investor interest and could lead to further price increases in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
INVO Bioscience's stock rose 46.18% to $0.24 during Monday's session, with a trading volume of 47.5 million.
INVO Bioscience's stock experienced a significant increase during Monday's session, with a trading volume much higher than its average full-day volume over the last 100 days. This indicates strong investor interest and could lead to further price increases in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
MoonLake's shares rose 66.94% to $43.2 during Monday's session, with a trading volume of 7.9 million.
MoonLake's shares experienced a significant increase during Monday's session, with a trading volume much higher than its average full-day volume over the last 100 days. This indicates strong investor interest and could lead to further price increases in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
ORIC Pharmaceuticals' stock moved upwards by 17.74% to $7.64 during Monday's session, with a trading volume of 792.9K.
ORIC Pharmaceuticals' stock experienced a significant increase during Monday's session, with a trading volume higher than its average full-day volume over the last 100 days. This indicates strong investor interest and could lead to further price increases in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Avalo Therapeutics' stock declined by 86.4% to $0.6 during Monday's session, with a trading volume of 23.7 million.
Avalo Therapeutics' stock experienced a significant decline during Monday's session, with a trading volume much higher than its average full-day volume over the last 100 days. This indicates strong selling pressure and could lead to further price decreases in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
BioVie's shares fell 23.85% to $4.44 during Monday's session, with a trading volume of 905.4K.
BioVie's shares experienced a significant decline during Monday's session, with a trading volume higher than its average full-day volume over the last 100 days. This indicates strong selling pressure and could lead to further price decreases in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Bio-Path Hldgs' stock decreased by 18.31% to $1.74 during Monday's session, with a trading volume of 56.1K.
Bio-Path Hldgs' stock experienced a significant decline during Monday's session, with a trading volume higher than its average full-day volume over the last 100 days. This indicates strong selling pressure and could lead to further price decreases in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
FibroGen's shares decreased by 82.69% to $2.78 during Monday's session, with a trading volume of 24.3 million.
FibroGen's shares experienced a significant decline during Monday's session, with a trading volume much higher than its average full-day volume over the last 100 days. This indicates strong selling pressure and could lead to further price decreases in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Pieris Pharmaceuticals' stock decreased by 21.36% to $0.19 during Monday's session, with a trading volume of 4.2 million.
Pieris Pharmaceuticals' stock experienced a significant decline during Monday's session, with a trading volume higher than its average full-day volume over the last 100 days. This indicates strong selling pressure and could lead to further price decreases in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Entrada Therapeutics' shares fell 19.41% to $11.88 during Monday's session, with a trading volume of 62.9K.
Entrada Therapeutics' shares experienced a significant decline during Monday's session, with a trading volume lower than its average full-day volume over the last 100 days. This indicates selling pressure and could lead to further price decreases in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100